0000000000596965

AUTHOR

Daniela Lucido

showing 24 related works from this author

Iperviscosita' sclerocitemica da alterazioni congenite della membrana eritrocitaria

2009

sferocitosi ellissocitosi spectrina
researchProduct

Protein oxidation in a group of subjects with metabolic syndrome.

2013

Abstract Aims To examine the protein oxidation, marker of the oxidative stress, in metabolic syndrome (MS). Methods We enrolled 106 subjects (45 women and 61 men) with MS of which 43 (14 women and 27 men) were with diabetes mellitus and 63 (31 women and 32 men) were without diabetes mellitus, and 54 subjects (19 women and 35 men) as control group. The protein oxidation, expressed as carbonyl groups, was measured by an enzyme-like immunosorbent assay (ELISA) kit (BioCell PC test kit, Enzo Life Sciences AG, Switzerland). Results In the whole group of MS subjects, in comparison with control group, a significant increase in carbonyl groups was present. The same datum was also evident between co…

Blood GlucoseMalemedicine.medical_specialtyWaistEndocrinology Diabetes and MetabolismIndiaBlood PressureProtein oxidationmedicine.disease_causeNitric OxideProtein CarbonylationInternal medicineDiabetes mellitusinsulin resistanceInternal MedicinemedicineHumansInflammationMetabolic Syndromeoxidative strebusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseOxidative StressEndocrinologyBlood pressureDiabetes Mellitus Type 2FemaleMetabolic syndromeWaist CircumferencebusinessOxidation-ReductionOxidative stressBiomarkersDiabetesmetabolic syndrome
researchProduct

Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according…

2006

An abnormal activation state of polymorphonuclear leukocytes (PMN) plays a key role in organ injury induced by vascular atherosclerotic disease (VAD) and diabetes mellitus (DM). PMN membrane fluidity and cytosolic Ca2+ content can be considered markers of PMN activation. In this research we evaluated the PMN membrane fluidity and cytosolic Ca2+ content in VAD subjects with and without type 2 DM and examined the association between these parameters and the mono- or polyvascular localization. We enrolled 155 VAD subjects, including 92 non-diabetic (group A: mean age 63.6 +/- 9.2 years) and 63 diabetic patients (group B: mean age 65.4 +/- 7.8 years). Among group A 63 patients had monovascular …

Vascular atherosclerotic disease type 2 diabetes mellitus polymorphonuclear leukocyte membrane fluidity polymorphonuclear leukocyte Ca2+ contentSettore MED/09 - Medicina Interna
researchProduct

Hemorheological pattern in different groups of athletes submitted to cardio-pulmonary exercise test

2007

blood viscosity endurance sports mixed sports power sports
researchProduct

Aortic aneurysm rupture into right atrium in patient with previous aortic valve replacement

2004

researchProduct

Comportamento delle gelatinasi e dei loro inibitori tissutali nella sindrome metabolica

2013

gelatinasi sindrome metabolica
researchProduct

Polymorphonuclear leukocyte integrin expression in subjects with type 1 and 2 diabetes mellitus

2005

researchProduct

Behaviour of the oxidative status in athletes before and after a cardio-pulmonary test

2008

oxidative stress lipid peroxidation antioxidant systems
researchProduct

Relationship between elastase and total antioxidant status in young subjects with recent myocardial infarction

2008

In a group of young subjects with acute myocardial infarction (AMI) (68 men and 7 women; mean age 39.6 ± 5.7 years) we examined the plasma concentration of elastase, the thiobarbituric acid-reactive substances (TBARS) and the total antioxidant status (TAS) at the initial stage of AMI. In this group we found an increase of elastase (p <0.001) and TBARS (p < 0.001) and a decrease of TAS (p < 0.001). A statistical correlation was observed in the whole group of AMI patients between plasma elastase and TAS (p < 0.01) and this correlation was more statistically significant in patients with more risk factors and not in those with more involved vessels.

AdultMaletotal antioxidant statusmedicine.medical_specialtyanimal structuresPhysiologyMyocardial InfarctionThiobarbituric Acid Reactive SubstancesGastroenterologyAntioxidantsPhysiology (medical)Internal medicineTBARSHumansMedicineIn patientMyocardial infarctionPancreatic Elastasebusiness.industryElastaseCase-control studyHematologyMiddle Agedmedicine.diseaseJuvenile myocardial infarctionplasma elastaseOxidative StressAntioxidant capacityCase-Control StudiesImmunologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersStatistical correlationRecent myocardial infarctionClinical Hemorheology and Microcirculation
researchProduct

ROTTURA DI UNA DISSEZIONE AORTICA IN ATRIO DESTRO IN PAZIENTE CON PREGRESSA SOSTITUZIONE VALVOLARE AORTICA

2004

researchProduct

OSSIDAZIONE LIPIDICA E PROTEICA, STATO ANTIOSSIDANTE TOTALE E METABOLITI STABILI DEL NITROSSIDO IN PAZIENTI CON SINDROME METABOLICA

2012

Settore MED/09 - Medicina InternaOSSIDAZIONE LIPIDICASINDROME METABOLICAANTIOSSIDANTEPROTEICANITROSSIDO
researchProduct

Polymorphonuclear leukocyte integrin profile in vascular atherosclerotic disease with and without type 2 diabetes mellitus.

2005

researchProduct

Alterazioni emoreologiche nella sindrome metabolica

2015

La sindrome metabolica (SM) si accompagna ad un elevato rischio cardiovascolare. Oltre ai tradizionali fattori di rischio, dei quali la SM rappresenta un’aggregazione, sono identificabili fattori non tradizionali quali l’assetto emoreologico. È noto da tempo che un disordine emoreologico si accompagna alla SM, ed è ipotizzabile una sua influenza sui meccanismi che instaurano e mantengono l’insulino-resistenza. In un gruppo di pazienti con SM abbiamo osservato un incremento della viscosità ematica e plasmatica e una riduzione della filtrabilità ematica. Il rapporto vita-fianchi, indice di obesità addominale, era direttamente correlato con la viscosità ematica e con l’ematocrito, mentre la vi…

stress ossidativoemoreologiaSindrome metabolicaSindrome metabolica; emoreologia; gelatinasi; stress ossidativogelatinasi
researchProduct

Erythrocyte deformability and nitric oxide metabolites in athletes before and after a cardio-pulmonary test

2008

nitrite nitrate exercise
researchProduct

Erythrocyte deformability and nitric oxide metabolites in athletes before and after a cardiopulmonary test.

2009

OBJECTIVE: To evaluate erythrocyte deformability, nitric oxide metabolites, and their modifications induced by exercise in athletes who practised different sports. DESIGN: This evaluation was effected before and after cardiopulmonary test, using a cycloergometer. SETTING: The study was performed in the Department of Internal Medicine, Cardiovascular and Renal Diseases of the University of Palermo. PARTICIPANTS: We enrolled 62 male athletes who practised endurance (n = 23), mixed (n = 20), and power (n = 19) sports and 20 sedentary male subjects as controls. ASSESSMENT OF RISK FACTORS: No subject had diabetes or hypertension or dyslipidemia. Five control subjects and 14 athletes were smokers…

AdultMalemedicine.medical_specialtyPhysical Therapy Sports Therapy and RehabilitationNitric OxideNitric oxideCardiovascular Physiological Phenomenachemistry.chemical_compoundGriess testInternal medicineDiabetes mellitusErythrocyte DeformabilitymedicineErythrocyte deformabilityHumansOrthopedics and Sports MedicineExercise physiologyNitriteExerciseNitritesNitratesbiologyAthletesbusiness.industryMiddle Agedmedicine.diseasebiology.organism_classificationerythrocyte deformabilityNOexerciseathletechemistryItalyAnesthesiaCardiologybusinessDyslipidemiaSportsClinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
researchProduct

Relationship between lipid peroxidation and total antioxidant status in juvenile myocardial infarction.

2007

researchProduct

Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according…

2005

researchProduct

Sindrome metabolica ed emoreologia

2011

Viscosità ematica viscosità plasmatica insulino-resistenza
researchProduct

Stress ossidativo in pazienti con sclerodermia: effetti dell’iloprost.

2007

researchProduct

Effetti dell’iloprost sulla disfunzione leucocitaria nella sclerodermia.

2007

researchProduct

Evaluation of nitric oxide production at the initial stage, 3 months and 12 months after juvenile myocardial infarction.

2007

researchProduct

Effetti emoreologici del trattamento con iloprost in pazienti con fenomeno di Raynaud secondario a sclerodermia.

2006

researchProduct

Granulocyte cytosolic Ca2+ content and beta2-integrin profile in type 2 diabetic subjects with and without macrovascular complications.

2006

researchProduct

Eventi vascolari correlati ad alcune condizioni di iperviscosità sclerocitemica

2014

Settore MED/09 - Medicina Internaerythrocyte membrane hereditary spherocytosis hereditary elliptocytosis acanthocytosis
researchProduct